1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Hematologic Disease and Disorders: new trials by email Literature Review of Hematologic Disease and Disorders trials Research Report on Hematologic Disease and Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide Tacrolimus, Cyclophosphamide, Mycofenolate mofetil - Hematologic Disease and Disorders, Hematopoietic Cell Transplant | Phase 2 | Recruiting | Northside Hospital, Inc. | 20 | 2025-07-03 | 2026-10-14 |
Disease (1) · Hematologic Diseases (1)
Hemic and Lymphatic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Cyclophosphamide (1) · Tacrolimus (1)
United States (1)
Melhem Solh, MD (1)
PMID 23233586, PMID 23423745, PMID 27318038, PMID 29421292, PMID 30953027, PMID 32645444, PMID 34262142, PMID 38281591, PMID 7742535, PMID 8877390